Sana Biotechnology, Inc. (SANA) Tops Q1 EPS by 4c

Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q1 EPS of ($0.43), $0.04 better than the analyst estimate of ($0.47).

For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.

You May Also Be Interested In

• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
• Jefferies Downgrades Pediatrix Medical Group (MD) to Hold
• Keysight Technologies (KEYS) Tops Q3 EPS by 59c; Offers Guidance